FDA clears new AI algorithm for 1-year AFib risk - Cardiovascular Business

Retrieved on: 2024-06-28 01:11:01

Tags for this article:

Click the tags to see associated articles and topics

FDA clears new AI algorithm for 1-year AFib risk - Cardiovascular Business. View article details on hiswai:

Excerpt

Chicago-based Tempus AI has gained clearance from the U.S. Food and Drug Administration (FDA) for a new artificial intelligence (AI) algorithm ...

Article found on: cardiovascularbusiness.com